Gait speed has comparable prognostic capability to six-minute walk distance in older patients with cardiovascular disease

Abstract

Background

Although gait speed and six-minute walk distance are used to assess functional capacity in older patients with cardiovascular disease, their prognostic capabilities have not been directly compared.

Methods

The study population was identified from the Kitasato University Cardiac Rehabilitation Database and consisted of 1474 patients ≥60 years old with a mean age of 72.2 ± 7.1 years that underwent evaluation of both usual gait speed and six-minute walk distance in routine geriatric assessment between 1 June 2008–30 September 2015. Both gait speed and six-minute walk distance were determined on the same day at hospital discharge.

Results

Mean gait speed and six-minute walk distance in the whole population were 1.04 m/s and 381 m, respectively, and were strongly positively correlated (r = 0.80, p < 0.001). A total of 180 deaths occurred during a follow-up of 2.3 ± 1.9 years. After adjusting for confounding factors, both gait speed (adjusted hazard ratio per 0.1 m/s increase: 0.87, 95% confidence interval: 0.81–0.93, p < 0.001) and six-minute walk distance (adjusted hazard ratio per 10-metre increase: 0.96, 95% confidence interval: 0.94–0.97, p < 0.001) were independent predictors of all-cause mortality. There was no significant difference in prognostic capability between gait speed and six-minute walk distance (c-index: 0.64 (95% confidence interval: 0.60–0.69) and 0.66 (95% confidence interval: 0.61–0.70), respectively, p = 0.357).

Conclusions

Gait speed and six-minute walk distance showed similar prognostic predictive ability for all-cause mortality in older cardiovascular disease patients, indicating the potential utility of gait speed as a simple risk stratification tool in older cardiovascular disease patients.

Keywords

Six-minute walk distance gait speed prognosis elderly sarcopenia frailty cardiovascular coronary artery disease heart failure cardiac surgery

Get full access to this article

View all access options for this article.

References

Vigorito

Abreu

Ambrosetti

et al.

Frailty and cardiac rehabilitation: A call to action from the EAPC Cardiac Rehabilitation Section. Eur J Prev Cardiol 2017; 24: 577–590.

Ekerstad

Swahn

Janzon

et al.

Frailty is independently associated with short-term outcomes for elderly patients with non-ST-segment elevation myocardial infarction. Circulation 2011; 124: 2397–2404.

Afilalo

Mottillo

Eisenberg

et al.

Addition of frailty and disability to cardiac surgery risk scores identifies elderly patients at high risk of mortality or major morbidity. Circ Cardiovasc Qual Outcomes 2012; 5: 222–228.

Kamiya

Masuda

Matsue

et al.

Prognostic usefulness of arm and calf circumference in patients ≥65 years of age with cardiovascular disease. Am J Cardiol 2017; 119: 186–191.

Ethgen

Beaudart

Buckinx

et al.

The future prevalence of sarcopenia in Europe: A claim for public health action. Calcif Tissue Int 2017; 100: 229–234.

La Rovere

Pinna

Maestri

et al.

The 6-minute walking test and all-cause mortality in patients undergoing a post-cardiac surgery rehabilitation program. Eur J Prev Cardiol 2015; 22: 20–26.

Prescher

Schoebel

Koehler

et al.

Prognostic value of serial six-minute walk tests using tele-accelerometry in patients with chronic heart failure: A pre-specified sub-study of the TIM-HF-Trial. Eur J Prev Cardiol 2016; 23: 21–26.

Tabata

Shimizu

Kamekawa

et al.

Six-minute walk distance is an independent predictor of hospital readmission in patients with chronic heart failure. Int Heart J 2014; 55: 331–336.

Beatty

Schiller

Whooley

. Six-minute walk test as a prognostic tool in stable coronary heart disease: Data from the heart and soul study. Arch Intern Med 2012; 172: 1096–1102.

10.

Cacciatore

Abete

Mazzella

et al.

Six-minute walking test but not ejection fraction predicts mortality in elderly patients undergoing cardiac rehabilitation following coronary artery bypass grafting. Eur J Prev Cardiol 2012; 19: 1401–1409.

11.

Afilalo

Eisenberg

Morin

et al.

Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol 2010; 56: 1668–1676.

12.

Studenski

Perera

Patel

et al.

Gait speed and survival in older adults. JAMA 2011; 305: 50–58.

13.

Pulignano

Del Sindaco

Di Lenarda

et al.

Incremental value of gait speed in predicting prognosis of older adults with heart failure: Insights from the IMAGE-HF study. J Am Coll Cardiol HF 2016; 4: 289–298.

14.

Fritz

Lusardi

. White paper: “Walking speed: the sixth vital sign”. J Geriatr Phys Ther 2009; 32: 46–49.

15.

Kim

Placide

et al.

Preoperative frailty assessment and outcomes at 6 months or later in older adults undergoing cardiac surgical procedures: A systematic review. Ann Intern Med 2016; 165: 650–660.

16.

Ando

Ito

Uemura

et al.

CKD clinical practice guidebook. The essence of treatment for CKD patients. Clin Exp Nephrol 2009; 13: 191–248.

17.

ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111–117.

18.

Steffen

Hacker

Mollinger

. Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds. Phys Ther 2002; 82: 128–137.

19.

Bittner

Weiner

Yusuf

et al.

Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA 1993; 270: 1702–1707.

20.

Metra

Ponikowski

Dickstein

et al.

Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2007; 9: 684–694.

21.

Fang

Ewald

Allen

et al.

Advanced (stage D) heart failure: A statement from the Heart Failure Society of America Guidelines Committee. J Card Fail 2015; 21: 519–534.

22.

Newman

Simonsick

Naydeck

et al.

Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. JAMA 2006; 295: 2018–2026.

23.

Morley

Abbatecola

Argiles

et al.

Sarcopenia with limited mobility: An international consensus. J Am Med Dir Assoc 2011; 12: 403–409.

24.

DeLong

Clarke-Pearson

. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988; 44: 837–845.

25.

Forman

Fleg

Kitzman

et al.

6-Min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure. J Am Coll Cardiol 2012; 60: 2653–2661.

26.

Kleczynski

Dziewierz

Bagienski

et al.

Impact of frailty on mortality after transcatheter aortic valve implantation. Am Heart J 2017; 185: 52–58.

27.

Purser

Kuchibhatla

Fillenbaum

et al.

Identifying frailty in hospitalized older adults with significant coronary artery disease. J Am Geriatr Soc 2006; 54: 1674–1681.

28.

Forman

Alexander

. Frailty – a vital sign for older adults with cardiovascular disease. Can J Cardiol 2016; 32: 1082–1087.

29.

Chen

Liu

Woo

et al.

Sarcopenia in Asia: Consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014; 15: 95–101.

30.

Working Group on Functional Outcome Measures for Clinical Trials. Functional outcomes for clinical trials in frail older persons: Time to be moving. J Gerontol A Biol Sci Med Sci 2008; 63: 160–164.

31.

Kamiya

Masuda

Tanaka

et al.

Quadriceps strength as a predictor of mortality in coronary artery disease. Am J Med 2015; 128: 1212–1219.

32.

Kamiya

Masuda

Matsue

et al.

Complementary role of arm circumference to body mass index in risk stratification in heart failure. J Am Coll Cardiol HF 2016; 4: 265–273.

33.

Schaap

Pluijm

Deeg

et al.

Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 2006; 119: 526.e9–17–526.e9–17.

34.

Beenakker

Ling

Meskers

et al.

Patterns of muscle strength loss with age in the general population and patients with a chronic inflammatory state. Ageing Res Rev 2010; 9: 431–436.

35.

Myers

Prakash

Froelicher

et al.

Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002; 346: 793–801.

36.

Corra

Agostoni

Giordano

et al.

The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study. Int J Cardiol 2016; 203: 1067–1072.

37.

Kamiya

Mezzani

Hotta

et al.

Quadriceps isometric strength as a predictor of exercise capacity in coronary artery disease patients. Eur J Prev Cardiol. 2014; 21: 1285–1291.

38.

Shimada

Suzuki

Suzukawa

et al.

Performance-based assessments and demand for personal care in older Japanese people: A cross-sectional study. BMJ Open 2013; 3: e002424.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.82 MB